Alternatives to Supernus Pharmaceuticals
Supernus Pharmaceuticals is a Biotechnology tool: biopharmaceutical company developing and commercializing CNS disease treatments. Here are the 53 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Biotechnology companies to Supernus Pharmaceuticals
Seaport TherapeuticsNot ratedDeveloping novel therapeutics to restore gut lymphatic function.
Degron TherapeuticsNot ratedClinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.
Tortugas NeuroscienceNot ratedAdvancing clinical stage pipeline targeting new and major neurology and neuropsychiatric disorders.
Draig TherapeuticsNot ratedClinical-stage biopharmaceutical company developing transformative, best-in-class neuropsychiatric therapies.
Aelis FarmaNot ratedClinical-stage biopharmaceutical company developing treatments for brain and peripheral disorders involving the CB1 receptor.
Moderna2.5 out of 5 (2)Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
- JUJuno TherapeuticsNot rated
Biotechnology company focused on developing cancer immunotherapies.
Kite PharmaNot ratedBiotechnology company developing and commercializing cell therapies for cancer treatment.
CRISPR TherapeuticsNot ratedBiotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology.
- CRCreate MedicinesNot rated
Developing in vivo immunotherapies for autoimmune diseases and cancer.
CellCentricNot ratedA clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.
InfinimmuneNot ratedDeveloping human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.
AdcendoNot ratedDeveloping first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.
EnteromeNot ratedClinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.
CelerionNot ratedA global leader in clinical pharmacology and bioanalytical sciences.
MironidNot ratedBiopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).
Spark TherapeuticsNot ratedA biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.
Precision BioSciencesNot ratedA clinical-stage biotechnology company developing in vivo gene editing therapies.
Janux TherapeuticsNot ratedA clinical-stage biopharmaceutical company developing novel immunotherapies.
Compass PathwaysNot ratedAccelerating patient access to evidence-based innovation in mental health.
Showing the next 20 closest matches. See the rest on the Supernus Pharmaceuticals profile.
Sponsored rows are paid and labelled. Advertise on this page
